Compositions and methods for treating hepatitis C virus

摘要

The invention relates to medicine, in particular to pharmacology and infectious diseases, namely to compositions and unit dosage forms for the treatment of hepatitis C virus infection.The pharmaceutical composition comprises:a) about 25% to about 35% w/w of crystalline form having the structure:(GS-7977); andb) at least one pharmaceutically acceptable excipient,wherein the crystalline GS-7977 has HRPD 2θ-reflections (°) at about: 6.1 and 12.7.According to the invention, also disclosed are methods of treating subjects infected with hepatitis C virus comprising administering to the subjects for a time period effective amounts of GS-7977 and of interferon-free ribavirin.